Retinoblastoma News and Research

RSS
A retinoblastoma is a malignant tumor of the retina, occurring most often in young children below 5 years. In one of three cases it is bilateral i.e., affecting both eyes. About 250-350 new cases occur every year in the USA, in children younger than 15 years.
Air quality and residential greenness influence childhood cancer development

Air quality and residential greenness influence childhood cancer development

CHLA researcher to lead a new study on liquid biopsy for diagnosing ocular cancer in children

CHLA researcher to lead a new study on liquid biopsy for diagnosing ocular cancer in children

Researchers develop a new smartphone-based tool to detect visual impairment in young children

Researchers develop a new smartphone-based tool to detect visual impairment in young children

Mediterranean diet may benefit health in part by incorporating moderate wine consumption

Mediterranean diet may benefit health in part by incorporating moderate wine consumption

Researchers discover a molecule that promotes tumor cell survival in retinoblastoma

Researchers discover a molecule that promotes tumor cell survival in retinoblastoma

Research brings us closer to optimizing treatments for children with retinoblastoma

Research brings us closer to optimizing treatments for children with retinoblastoma

Death from retinoblastoma is more common among children in low-income countries

Death from retinoblastoma is more common among children in low-income countries

Study finds higher risk of all-cause mortality among pediatric cancer patients in LMICs during the pandemic

Study finds higher risk of all-cause mortality among pediatric cancer patients in LMICs during the pandemic

Infantile cataracts are more common and problematic than thought

Infantile cataracts are more common and problematic than thought

Researchers create new model for studying earliest stages of retinoblastoma

Researchers create new model for studying earliest stages of retinoblastoma

Candy-like models could make science more accessible to visually impaired students

Candy-like models could make science more accessible to visually impaired students

Cognitive outcomes in survivors of childhood cancers have been largely understudied

Cognitive outcomes in survivors of childhood cancers have been largely understudied

Proteogenomics can help determine effective treatment for head and neck squamous cell carcinoma

Proteogenomics can help determine effective treatment for head and neck squamous cell carcinoma

Cellular senescence variations may control health and onset of age-related diseases

Cellular senescence variations may control health and onset of age-related diseases

Two young scientists receive Damon Runyon-Sohn Pediatric Cancer Fellowship Award

Two young scientists receive Damon Runyon-Sohn Pediatric Cancer Fellowship Award

Subpopulations of tumor cells may exhibit diverging behaviors from bulk tumor

Subpopulations of tumor cells may exhibit diverging behaviors from bulk tumor

Novel detection method for retinoblastoma

Novel detection method for retinoblastoma

Biomarker reveals if benign-appearing meningiomas are dangerous

Biomarker reveals if benign-appearing meningiomas are dangerous

Researchers discover way to find genetic tumor information of retinoblastoma

Researchers discover way to find genetic tumor information of retinoblastoma

Eye disease in infants detected using smartphone app

Eye disease in infants detected using smartphone app

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.